Matinas Biopharma Holdings, Inc. posts $0 million annual profit
By USInMinutes
Published - Mar 19, 2023, 04:28 PM ET
Last Updated - Jul 18, 2023, 04:13 PM EDT
Matinas Biopharma Holdings, Inc. [MTNB] has posted annual profit of $0 million for the year ended Dec 31,2022.
The company based in New Jersey(NJ)reported a fellin revenue to $0 milion for the year when compared to $0.0333 million in the previous year.
A filing from the company with the Securities and Exchange Commission on Mar 15,2023 showed that its revenue is up 100.00% year-over-year.
The company reported basic earnings per share of $0 and diluted earnings per share of $0.
Matinas Biopharma Holdings, Inc. operates in the Pharmaceutical Preparations sector.
Related News
--------
NewsInMinutes: is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts.